Gliclazide:MCnc:Pt:Ser/Plas:Qn

Known as: Gliclazide:Massa concentratie:Moment:Serum of plasma:Kwantitatief, Gliclazida::Pt:Soro/Plas:Qn, ?????????:????????:??????:???/????:????? 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundAlthough the number of antihyperglycemic agents has expanded significantly, sulfonylureas (in particular gliclazide… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Background and objectiveGliclazide is a drug commonly used in type 2 diabetes mellitus. Recently, gliclazide has shown desirable… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
A modified release gliclazide 60 mg tablet using Methocel® K100 Premium LV DC2 as a drug retaining polymer was prepared by… (More)
Is this relevant?
2012
2012
Objective of this study was to formulate directly compressible fast dissolving tablets of Gliclazide with sufficient mechanical… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2010
2010
OBJECTIVE To compare the efficacy and tolerability of metformin, rosiglitazone and gliclazide MR as monotherapy and in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Progressive beta-cell failure is a characteristic feature of type 2 diabetes; consequently, beta-cell secretagogues… (More)
Is this relevant?
Review
2002
Review
2002
Abstract▴ Gliclazide modified release (MR) is a new formulation of the drug gliclazide and is given once daily. The hydrophilic… (More)
  • figure 1
  • figure 2
Is this relevant?